Edinburgh Urological Cancer Group
Grant D. Stewart has not added Biography.
If you are Grant D. Stewart and would like to personalize this page please email our Author Liaison for assistance.
What are the oncological risks of minimal access surgery for the treatment of urinary tract cancer?
European urology Oct, 2004 | Pubmed ID: 15363552
Oncological control following laparoscopic nephroureterectomy: 7-year outcome.
The Journal of urology Nov, 2004 | Pubmed ID: 15540724
A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.
BJU international Apr, 2005 | Pubmed ID: 15794784
Laparoscopic suturing: effect of instrument handling on suture strength.
Journal of endourology / Endourological Society Nov, 2005 | Pubmed ID: 16283852
Cancer cachexia and fatigue.
Clinical medicine (London, England) Mar-Apr, 2006 | Pubmed ID: 16688969
Surgical service centralisation in Australia versus choice and quality of life for rural patients.
The Medical journal of Australia Aug, 2006 | Pubmed ID: 16893360
Controversial cases in endourology.
Journal of endourology / Endourological Society Sep, 2006 | Pubmed ID: 16999609
Results of a definitive study are needed to provide guidance on the treatment of patients with screen-detected, 'low-grade' prostate cancer.
BJU international Nov, 2006 | Pubmed ID: 17034595
Total joint replacement surgery in a rural centre.
The Australian journal of rural health Dec, 2006 | Pubmed ID: 17121504
Pathophysiology of cancer cachexia: much more than host-tumour interaction?
Clinical nutrition (Edinburgh, Scotland) Dec, 2007 | Pubmed ID: 17507116
Dermcidin expression confers a survival advantage in prostate cancer cells subjected to oxidative stress or hypoxia.
The Prostate Sep, 2007 | Pubmed ID: 17626247
Is there a human homologue to the murine proteolysis-inducing factor?
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2007 | Pubmed ID: 17785548
The dermcidin gene in cancer: role in cachexia, carcinogenesis and tumour cell survival.
Current opinion in clinical nutrition and metabolic care May, 2008 | Pubmed ID: 18403914
Re: androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response.
European urology May, 2008 | Pubmed ID: 18485321
NO-sulindac inhibits the hypoxia response of PC-3 prostate cancer cells via the Akt signalling pathway.
International journal of cancer. Journal international du cancer Jan, 2009 | Pubmed ID: 18924134
Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score.
Oncology reports Dec, 2008 | Pubmed ID: 19020742
The continuing medical education activities and attitudes of Australian doctors working in different clinical specialties and practice locations.
Australian health review : a publication of the Australian Hospital Association Feb, 2009 | Pubmed ID: 19203333
The relevance of a hypoxic tumour microenvironment in prostate cancer.
BJU international Jan, 2010 | Pubmed ID: 19889065
Mass spectrometric detection of candidate protein biomarkers of cancer cachexia in human urine.
International journal of oncology Apr, 2010 | Pubmed ID: 20198343
DNA strand breaks and hypoxia response inhibition mediate the radiosensitisation effect of nitric oxide donors on prostate cancer under varying oxygen conditions.
Biochemical pharmacology Jan, 2011 | Pubmed ID: 20888325
Functional and oncological outcomes of men under 60 years of age having endoscopic surgery for prostate cancer are optimal following intrafascial endoscopic extraperitoneal radical prostatectomy.
The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland Apr, 2011 | Pubmed ID: 21342669
Utilizing mRNA extracted from small, archival formalin-fixed paraffin-embedded prostate samples for translational research: assessment of the effect of increasing sample age and storage temperature.
International urology and nephrology Dec, 2011 | Pubmed ID: 21448682
What can molecular pathology contribute to the management of renal cell carcinoma?
Nature reviews. Urology May, 2011 | Pubmed ID: 21487387
Proteolysis-inducing factor core peptide mediates dermcidin-induced proliferation of hepatic cells through multiple signalling networks.
International journal of oncology Sep, 2011 | Pubmed ID: 21643625
A novel bovine model for training urological surgeons in laparoscopic radical nephrectomy.
Journal of endourology / Endourological Society Aug, 2011 | Pubmed ID: 21751881
Long-term comparative outcomes of open versus laparoscopic nephroureterectomy for upper urinary tract urothelial-cell carcinoma after a median follow-up of 13 years*.
Journal of endourology / Endourological Society Aug, 2011 | Pubmed ID: 21815793
Yes to careful introduction of robot assisted surgery.
BMJ (Clinical research ed.) , 2011 | Pubmed ID: 22077086
The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer.
BJU international Sep, 2012 | Pubmed ID: 22289017
The use of automated quantitative analysis to evaluate epithelial-to-mesenchymal transition associated proteins in clear cell renal cell carcinoma.
PloS one , 2012 | Pubmed ID: 22363672
Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
BJU international Sep, 2012 | Pubmed ID: 22471401
Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
BJU international Dec, 2012 | Pubmed ID: 22564677
Description and validation of a modular training system for laparoscopic nephrectomy.
Journal of endourology / Endourological Society Nov, 2012 | Pubmed ID: 22642561
Stromal expression of decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in developing prostate and decreased levels of decorin in prostate cancer.
PloS one , 2012 | Pubmed ID: 22880013
Adult prepuceplasty: comparison of outcomes of standard prepuceplasty and foreskin Z-plasty.
Urology Oct, 2012 | Pubmed ID: 22921703
Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study.
The Journal of urology Sep, 2012 | Pubmed ID: 22999998
A unique case of an alpha-fetoprotein-producing lung cancer with testicular metastasis.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada Oct, 2012 | Pubmed ID: 23093628
Reduction of pro-tumorigenic activity of human prostate cancer-associated fibroblasts using Dlk1 or SCUBE1.
Disease models & mechanisms Nov, 2012 | Pubmed ID: 23136397
Polyarteritis nodosa presenting as haematuria following strenuous exercise.
BMJ case reports , 2012 | Pubmed ID: 23188866
Endoscopic versus Laparoscopic Management of Non-Invasive Upper Tract Urothelial Carcinoma (UTUC): 20-year Single Centre Experience.
The Journal of urology Dec, 2012 | Pubmed ID: 23228378
Fiach C. O'Mahony1,
Jyoti Nanda1,
Alexander Laird1,
Peter Mullen2,
Helen Caldwell3,
Ian M. Overton4,
Lel Eory4,
Marie O'Donnell1,5,
Dana Faratian6,
Thomas Powles7,
David J. Harrison1,2,
Grant D. Stewart1
1Edinburgh Urological Cancer Group, University of Edinburgh,
2School of Medicine, University of St Andrews,
3Division of Pathology, University of Edinburgh,
4MRC Human Genetics Unit, MRC IGMM, University of Edinburgh,
5Department of Pathology, Western General Hospital,
6Breakthrough Breast Cancer Research Unit, University of Edinburgh,
7St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados